[Retracted] Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data

Figure 4

Clinical multifactorial expression of PROK1 and PROK2. (a) Expression of PROK1 and PROK2 in tumor tissue. (b) Expression of low and high concentrations of PROK1 and PROK2 in WHO grade. (c) Expression of low and high concentrations of PROK1 and PROK2 in gender. (d) Expression of low and high concentrations of PROK1 and PROK2 in age. (e) Expression of low and high concentrations of PROK1 and PROK2 in IDH status. (f) Expression of low and high concentrations of PROK1 and PROK2 in histological type. (g) Expression of low and high concentrations of PROK1 and PROK2 in 1p/19q codeletion.

(a)

(b)

(c)

(d)

(e)

(f)

(g)